logo for Sensei Biotherapeutics

Sensei Biotherapeutics

Manufacturing · Maryland, United States · 28 Employees

View Company Info for Free

About

Headquarters

1405 Research Blvd Ste 125, Rockville, Maryland...

Phone Number

(240) 243-8000

Revenue

$9.5 Million

Stock Symbol

SNSE

Industry

Pharmaceuticals Healthcare

Highlights

$361.1M

Total Funding Amount

$150M

Most Recent Funding Amount

4

Number of Funding Rounds

Who is Sensei Biotherapeutics

Sensei Biotherapeutics is a biopharmaceutical company engaged in discovery, development and delivery of next generation immunotherapies with an initial focus on treatments for cancer. Sensei has developed two unique approaches - its TMAb (Tumor Microenvironment Activated biologics) platform, comprising unique human monoclonal antibodies and alpaca derived nanobodies that are selectively active in the tumor microenvironment, and its ImmunoPhage platform that leverages bacteriophage to drive the generation of tumor antigen-specific immune responses. Using its TMAb platform, the company has developed SNS-101, an antibody-based therapeutic targeting an immune checkpoint gene that inhibits anti-tumor immune responses called V-domain Ig suppressor of T cell activation (VISTA). Using the ImmunoPhage platform, Sensei is developing a library of ImmunoPhage, called Phortress, with multiple tumor-associated antigens to create a personalized, yet off-the-shelf cocktail approach for treating cancer patients. The platform is designed to enable efficient, scalable and cost-effective manufacturing to support all of Sensei's clinical programs. SNS-401-NG is an ImmunoPhage cocktail in preclinical development for the treatment of Merkel Cell Carcinoma.Read more

Sensei Biotherapeutics's Social MediaPopular SearchesSensei Biotherapeutics IncSensei BiotherapeuticsSensei BioBiotherapeutics IncSensei Bio Subsidiary IncSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: SNSEShow more

Sensei Biotherapeutics Org Chart

PhoneEmail
Erin Colgan

Chief Financial Officer, Thought & Leader

PhoneEmail

PhoneEmail

PhoneEmail

Similar Companies to Sensei Biotherapeutics

See more similar companies

Sensei Biotherapeutics Company Metrics

Company Insights
Employee Growth Rate
Funding
Funding DateMar 16, 2022
RoundStock Issuance/Offering
Amount$150M
Investors
Funding DateFeb 10, 2021
RoundStock Issuance/Offering
Amount$152.6M
Investors
Funding DateJan 11, 2021
RoundSeries B
Amount$30M
InvestorsPURA VIDA INVESTMENTS, Moore Strategic Ventures, Apeiron Investment Group Ltd, Catalio Capital Management, Cambrian Biopharma
See More

$361.1M

Total Funding Amount

$150M

Most Recent Funding Amount

4

Number of Funding Rounds

Sensei Biotherapeutics Tech Stack

A closer look at the technologies used by Sensei Biotherapeutics

Top Companies in United States

Top 10 companies in United States by revenue

Top 10 companies in United States by number of employees

Top 10 companies in United States by total funding amount

See top companies

Sensei Biotherapeutics News & Media

Read more news

Frequently Asked Questions regarding Sensei Biotherapeutics

Where is Sensei Biotherapeutics located?
Sensei Biotherapeutics's headquarters are located at 1405 Research Blvd Ste 125, Rockville, Maryland, 20850, United States
What is Sensei Biotherapeutics's phone number?
Sensei Biotherapeutics's phone number is (240) 243-8000
What is Sensei Biotherapeutics's stock symbol?
Sensei Biotherapeutics's stock symbol is SNSE
What is Sensei Biotherapeutics's official website?
Sensei Biotherapeutics's official website is www.senseibio.com
What is Sensei Biotherapeutics's Revenue?
Sensei Biotherapeutics's revenue is $9.5 Million
What is Sensei Biotherapeutics's SIC code?
Sensei Biotherapeutics's SIC: 28,283
What is Sensei Biotherapeutics's NAICS code?
Sensei Biotherapeutics's NAICS: 32,325
How many employees does Sensei Biotherapeutics have?
Sensei Biotherapeutics has 28 employees
What industry does Sensei Biotherapeutics belong to?
Sensei Biotherapeutics is in the industry of: Pharmaceuticals, Healthcare
What is Sensei Biotherapeutics competition?
Sensei Biotherapeutics top competitors include: Checkmate Pharmaceuticals, Galera Therapeutics, CEL-SCI, Synthorx
What technology does Sensei Biotherapeutics use?
Some of the popular technologies that Sensei Biotherapeutics uses are: WordPress.org, Drupal, reCAPTCHA, PHP
Who is the CFO of Sensei Biotherapeutics?
Sensei Biotherapeutics's CFO is Erin Colgan
How do I contact Sensei Biotherapeutics?
Sensei Biotherapeutics contact info: Phone number: (240) 243-8000 Website: www.senseibio.com
What does Sensei Biotherapeutics do?

Sensei Biotherapeutics is a biopharmaceutical company engaged in discovery, development and delivery of next generation immunotherapies with an initial focus on treatments for cancer. Sensei has developed two unique approaches - its TMAb (Tumor Microenvironment Activated biologics) platform, comprising unique human monoclonal antibodies and alpaca... derived nanobodies that are selectively active in the tumor microenvironment, and its ImmunoPhage platform that leverages bacteriophage to drive the generation of tumor antigen-specific immune responses. Using its TMAb platform, the company has developed SNS-101, an antibody-based therapeutic targeting an immune checkpoint gene that inhibits anti-tumor immune responses called V-domain Ig suppressor of T cell activation (VISTA). Using the ImmunoPhage platform, Sensei is developing a library of ImmunoPhage, called Phortress, with multiple tumor-associated antigens to create a personalized, yet off-the-shelf cocktail approach for treating cancer patients. The platform is designed to enable efficient, scalable and cost-effective manufacturing to support all of Sensei's clinical programs. SNS-401-NG is an ImmunoPhage cocktail in preclinical development for the treatment of Merkel Cell Carcinoma.Read More

What are Sensei Biotherapeutics social media links?
Sensei Biotherapeutics Linkedin page Sensei Biotherapeutics Twitter page
How much funding has Sensei Biotherapeutics raised to date?
Sensei Biotherapeutics has raised $361.1 Million in 4 funding rounds
When was the last funding round for Sensei Biotherapeutics?
Sensei Biotherapeutics closed its last funding round on Mar 16, 2022 with the amount of $150 Million
Who invested in Sensei Biotherapeutics?
Sensei Biotherapeutics has 12 investors including Future Ventures, Presight Ventures, Cambrian Biopharma and Apeiron Investment Group.
Is Sensei Biotherapeutics a public company?
Yes, Sensei Biotherapeutics is a public company and is traded under the symbol SNSE
See more information about Sensei Biotherapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.